Home > Back to Publisher > Report Information

U.S. Emerging Osteoporosis Therapeutics Markets

Frost & Sullivan
April 1, 2002
SKU: MC763973

Abstract Table of Contents Related Reports

Countries covered: United States

U.S. Emerging Osteoporosis Therapeutics Markets

Lack of Disease Awareness Restrains Industry Growth

Many doctors and potential patients remain unaware of the signs of osteoporosis, which is characterized by low bone mass and structural deterioration of bone tissue. Consequently, only one-third of the 10 million Americans suffering from this progressive disease are diagnosed and treated for their condition. As long as awareness remains low, markets for therapeutics will fall short of their revenue potential.

This Frost & Sullivan study analyzes the U.S. markets for osteoporosis therapeutics, including markets for estrogen replacement therapy (ERT), biphosphonates, selective estrogen receptor modulators, calcitonin, and other emerging therapies. By examining market drivers and restraints and by presenting expert revenue forecasts for each segment, this study gives its readers key insights into the future of this field.

Product Differentiation Is Crucial to Introducing New Therapies

"Drug companies with novel drugs in the pipeline for the prevention and treatment of osteoporosis are challenged to differentiate their new products from existing therapies," says the study’s author. Because estrogen therapies, for example, are viewed as clinically similar, doctors tend to pass over new products for drugs that they regularly prescribe.

"Until market participants can successfully differentiate their products from those of their competitors, they will not succeed in unseating traditional market leaders," states the analyst. This study, which highlights industry challenges and provides extensive strategic recommendations, can help your firm increase its market presence.

Bone Formation Drugs Promise New Opportunities

Existing anti-resorptive therapies are unable to replace lost bone or rebuild new bone mass. As a result, patients with severe osteoporosis are at a very high risk of developing fractures. Drug companies have responded to this unmet medical need by developing bone formation drugs, such as the parathyroid hormone, which have the potential to reverse bone loss and rebuild bone density in patients with advanced osteoporosis.

"The development of bone formation drugs will revolutionize the osteoporosis market. Demand will be high among patients who have failed existing therapies," says the author. This study tracks the progress of new therapies to enable your company to optimize its research and development efforts.

Additional Information

Market Participants
Amgen, Inc.
Aventis Pharmaceuticals, Inc.
Berlex Laboratories, Inc.
Bone Care International, Inc.
Bristol-Myers Squibb Co.
Discovery Labs, Inc.
Eli Lilly & Company
Emisphere Technologies, Inc.
GlaxoSmithKline Plc
Inhale Therapeutic Systems, Inc.
Insmed, Inc.
Ligand Pharmaceuticals, Inc.
Merck & Co., Inc.
Mission Pharmacal Co.
Mylan Laboratories, Inc.
Nobex Corp.
Novartis Pharmaceutical Corp.
Novavax, Inc.
Noven Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc.
Organon, Inc.
Pfizer, Inc.
Pharmacia Corporation
Procter & Gamble Pharmaceuticals, Inc.
Qualitest Pharmaceuticals, Inc.
Roche US Pharmaceuticals
Solvay Pharmaceuticals, Inc.
TheraTechnologies, Inc.
Unigene Laboratories, Inc.
Watson Pharmaceuticals, Inc.
Women First HealthCare, Inc.
Wyeth-Ayrest Laboratories
Aerospace
Auto ID
Biotech
Chemicals
Conferencing
Consumer
e-Business
Environment
Food
Healthcare
Internet Security
IT
Latin America
Medical Devices
Motors
Pharmaceuticals
Power
Sensors
Smart Cards
Technical Insights
Telecom Services
Transportation
Water
Wireless

1. Executive Summary
A. Executive Summary
1. Executive Summary

2. Introduction
A. Overview
1. Scope and Segmentation
2. Disease Definition And Pathogenesis
3. Types of Osteoporosis
4. Risk Factors
5. Symptoms
6. Diagnosis
7. Prevention and Treatment
8. Cost of Osteoporotic Fractures
9. Challenges
10. Market Drivers
11. Market Restraints
B. Market Dynamics
1. Demand Analysis
2. Market and Technology Trends
C. Strategic Recommendations
1. Strategies Overview
2. Strategic Recommendations for Market Challenge 1
3. Strategic Recommendations for Market Challenge 2
4. Strategic Recommendations for Market Challenge 3
D. Frost & Sullivan Market Engineering Awards
1. Technology Innovation Award
2. Strategic Alliance Innovation Award
3. Technology Leadership Award
4. Business Development Strategy Award
5. Product Line Strategy Award

3. Estrogen Replacement Therapy Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging

4. Biphosphonates Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging

5. Selective Estrogen Receptor Modulator Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging

6. Calcitonin Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging

7. Other Emerging Osteoporosis Therapeutics Market
A. Overview
1. Introduction
2. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Product Analysis

List of Figures

Chapter 2
Emerging Osteoporosis Therapeutics Markets: Leading Risk Factors For Women And Men (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Total Number of Osteoporotic Fractures (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Cost Of Osteoporotic Fractures (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Impact of Top Ten Industry Challenges (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Total Population Forecast By Age Group (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Population Forecast By Gender And Age Group (U.S.), 2001-2050
Emerging Osteoporosis Therapeutics Markets: Low Bone Mass And Osteoporosis Prevalence By Gender In People Aged 50 And Over (U.S.), 2001-2020
Emerging Osteoporosis Therapeutic Markets: Strategies Addressing Market Challenges (U.S.), 2001

Chapter 3
Estrogen Replacement Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Estrogen Replacement Therapy Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Estrogen Replacement Therapy Market: Revenue Forecast (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Revenue Forecast By Product Class (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Percentage Of Revenues By Product Class (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Product Pricing - Oral ERT(U.S.), 2001
Estrogen Replacement Therapy Market: Product Pricing-ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Monthly Cost Of Treatment-Oral ERT (U.S.), 2001
Estrogen Replacement Therapy Market: Monthly Cost Of Treatment-ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Competitive Structure (U.S.), 2001
Estrogen Replacement Therapy Market: Market Share Analysis (U.S.), 2000-2001
Estrogen Replacement Therapy Market: Product Analysis-Existing Oral (U.S.), 2001
Estrogen Replacement Therapy Market: Product Analysis-Existing ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Product Analysis-Emerging (U.S.), 2001

Chapter 4
Biphosphonates Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Biphosphonates Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Biphosphonates Market: Revenue Forecast (U.S.), 1998-2008
Biphosphonates Market: Product Pricing (U.S.), 2001
Biphosphonates Market: Monthly Cost Of Treatment (U.S.), 2001
Biphosphonates Market: Competitive Structure (U.S.), 2001
Biphosphonates Market: Market Share Analysis (U.S.), 2000-2001
Biphosphonates Market Therapeutics Market: Product Analysis-Existing (U.S.), 2001
Biphosphonates Market: Product Analysis-Emerging (U.S.), 2001

Chapter 5
Selective Estrogen Receptor Modulator Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Selective Estrogen Receptor Modulator Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Selective Estrogen Receptor Modulator Market: Revenue Forecast (U.S.), 1998-2008
Selective Estrogen Receptor Modulator Market: Product Pricing (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Monthly Cost Of Treatment (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Competitive Structure (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Market Share Analysis (U.S.), 2000-2001
Selective Estrogen Receptor Modulator Market: Product Analysis-Existing (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Product Analysis-Emerging (U.S.), 2001

Chapter 6
Calcitonin Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Calcitonin Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Calcitonin Market: Revenue Forecast (U.S.), 1998-2008
Calcitonin Market: Product Pricing (U.S.), 2001
Calcitonin Market: Monthly Cost Of Treatment (U.S.), 2001
Calcitonin Market: Competitive Structure (U.S.), 2001
Calcitonin Market: Market Share Analysis (U.S.), 2000-2001
Calcitonin Market: Product Analysis-Existing (U.S.), 2001
Calcitonin Market: Product Analysis-Emerging (U.S.), 2001

Chapter 7
Other Emerging Osteoporosis Therapeutics Market: Revenue Forecast (U.S.), 1998-2008
Other Emerging Osteoporosis Therapeutics Market: Competitive Structure (U.S.), 2001
Other Emerging Osteoporosis Therapeutics Market: Product Analysis (U.S.), 2001

More United States Disease Management Reports

2012 Healthcare Business Market Research Handbook by Richard K. Miller & Associates
The 2012 Healthcare Business Market Research Handbook presents a comprehensive analysis of the $2.8 trillion U.S. healthcare marketplace with the most recent statistics and data ...

Market Access in the United States: An Uncertain Outlook by Decision Resources
The outlook for the U.S. pharmaceutical market is more uncertain than at any other time in recent years. The number of uninsured residents and Medicaid ...

Freedonia Focus on Infection Prevention Products & Services by Freedonia Focus
This report discusses US demand for infection prevention products and services for the years 2005 and 2010, with forecasts for 2015. Topics covered include ...

Infection Prevention Products & Services by Freedonia Group Inc
US demand to rise 5.1% annually through 2015 US demand for infection prevention products and services is forecast to increase 5.1 percent annually to $21.4 ...

Monetizing Telemedicine: Vendors, Service Providers, and Payers Opportunities - Report 1: Describing the Telemedicine Landscape in the United States by IDC
This IDC Health Insights report examines the evolving telemedicine market in the United States, defines a telemedicine, identifies technology and customer segments, and discusses key ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

U.S. Emerging Osteoporosis Therapeutics Markets

Share this report

Other tasks

Research Assistance

Related Markets

Disease Management Reports

Free Alert Me service